Skip to content
Home/Companies/Biotech/PepGen

PepGen

Biotech·United States·Exited 2022·Held 4yr
Entry
2018
Hold
4yr
Exit
2022

Who owns PepGen?

PepGen was owned by Oxford Science Enterprises through Oxford Science Enterprises Balance Sheet (2015 vintage) from 2018 to 2022, exited via IPO.

Hand-verified · updated 2026-06-11

Oxford Science Enterprises
Investor
Oxford Science Enterprises
Oxford Science Enterprises Balance Sheet · 2015 · Balance Sheet

Key facts

HQUnited States
SectorBiotech
StatusActive
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2022

More from Oxford Science Enterprises Balance Sheet

Other portfolio companies in the same fund.

Allos
Allos
Active
AI/MLUK· 2026
Caudal Energy
Active
EnergyUK· 2026
Densix
Active
Deep TechUK· 2026
Marley Health
Marley Health
Active
HealthTechUK· 2026
Stateful Robotics
Stateful Robotics
Active
Deep TechUK· 2026
Alethio Therapeutics
Active
BiotechUK· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track PepGen

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on PepGen.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue